Search Results

CLOUT Registry’s 2-Year Outcomes Reported for Inari’s ClotTriever to Treat DVT

November 4, 2024—Two-year outcomes were reported from the CLOUT registry, which is a prospective, multicenter study evaluating patient outcomes after mechanical thrombectomy (MT) with the ClotTriever system (Inari Medical) in proximal lower extremity deep vein thrombosis (DVT).

Inari’s ClotTriever for DVT Evaluated at 1 Year in CLOUT Registry

October 30, 2023—The CLOUT (ClotTriever Outcomes) registry is a prospective, multicenter study evaluating patient outcomes for proximal lower extremity deep vein thrombosis (DVT) treated with mechanical thrombectomy (MT) using the ClotTriever system (Inari Medical).

Early Outcomes Presented for Inari's ClotTriever System to Treat DVT

November 6, 2019—Inari Medical, Inc. announced the presentation of early outcomes from CLOUT, the ClotTriever Outcomes Registry evaluating the company’s ClotTriever mechanical thrombectomy system for treatment of acute and chronic lower extremity deep vein thrombosis (DVT).

Mercator’s Bullfrog Microinfusion Device Studied in DEXTERITY-AFP for Local Delivery of Anti-Inflammation Drug in DVT

October 30, 2023—The DEXTERITY-AFP trial is a phase 2, multisite trial investigating Bullfrog microinfusion device (Mercator MedSystems, Inc.) perivenous injection of dexamethasone sodium phosphate injection USP combined with contrast and at a dosage of 2 mL (6.4 mg) each 5 cm of treatment length to improve patency and post-thrombotic syndrome (PTS) 6 months after thrombus removal in symptomatic deep vein thrombosis (DVT) spanning into at least the common femoral, femoral, and/or popliteal veins.

Gore Commences Pivotal VIAFORT Vascular Stent Iliofemoral Study

June 6, 2023—Gore & Associates announced that the first United States patient has been enrolled in a prospective nonrandomized multicenter single-arm pivotal study with 5-year follow-up to evaluate the Viafort vascular stent for the treatment of symptomatic iliofemoral venous obstruction.

Vascular Access With Merit’s Wrapsody CIE Studied in WRAP North America Registry

August 18, 2025—Merit Medical Systems, Inc. announced that the first patient was enrolled in the company’s WRAP North America registry, which is evaluating the company’s Wrapsody cell-impermeable endoprosthesis (CIE).